C9orf72 hexanucleotide expansions are associated with altered ER calcium homeostasis and stress granule formation in iPSC-derived neurons from patients with amyotrophic lateral sclerosis and frontotemporal dementia

<p>An expanded hexanucleotide repeat in a noncoding region of the <em>C9orf72</em> gene is a major cause of amyotrophic lateral sclerosis (ALS), accounting for up to 40andpercnt; of familial cases and 7andpercnt; of sporadic ALS in European populations. We have generated induced pl...

Full description

Bibliographic Details
Main Authors: Dafinca, R, Scaber, J, Ababneh, N, Lalic, T, Weir, G, Christian, H, Vowles, J, Douglas, A, Fletcher-Jones, A, Browne, C, Nakanishi, M, Turner, M, Wade-Martins, R, Cowley, S, Talbot, K
Format: Journal article
Published: Wiley 2016
Description
Summary:<p>An expanded hexanucleotide repeat in a noncoding region of the <em>C9orf72</em> gene is a major cause of amyotrophic lateral sclerosis (ALS), accounting for up to 40andpercnt; of familial cases and 7andpercnt; of sporadic ALS in European populations. We have generated induced pluripotent stem cells (iPSCs) from fibroblasts of patients carrying <em>C9orf72</em> hexanucleotide expansions, differentiated these to functional motor and cortical neurons and performed an extensive phenotypic characterization. In <em>C9orf72</em> iPSC-derived motor neurons, decreased cell survival is correlated with dysfunction in Ca<sup>2+</sup> homeostasis, reduced levels of the anti-apoptotic protein Bcl-2, increased endoplasmic reticulum (ER) stress and reduced mitochondrial membrane potential. Furthermore, <em>C9orf72</em> motor neurons, and also cortical neurons, show evidence of abnormal protein aggregation and stress granule formation. This study is an extensive characterization of iPSC-derived motor neurons as cellular models of ALS carrying <em>C9orf72</em> hexanucleotide repeats, which describes a novel pathogenic link between <em>C9orf72</em> mutations, dysregulation of calcium signalling and altered proteostasis and provides a potential pharmacological target for the treatment of ALS and the related neurodegenerative disease frontotemporal dementia (FTD).</p>